Y. Ajavon

605 total citations
16 papers, 336 citations indexed

About

Y. Ajavon is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Y. Ajavon has authored 16 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 7 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Y. Ajavon's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease and Transplantation (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Y. Ajavon is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease and Transplantation (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Y. Ajavon collaborates with scholars based in France, Belgium and Italy. Y. Ajavon's co-authors include N. Sellier, Olivier Séror, Michel Beaugrand, Nathalie Ganne‐Carrié, Jean–Claude Trinchet, G. Nkontchou, Jean Claude Trinchet, Véronique Grando–Lemaire, Emmanuelle Coderc and Laurent Castéra and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and Radiographics.

In The Last Decade

Y. Ajavon

15 papers receiving 330 citations

Peers

Y. Ajavon

HEPAT

EPIDE

SURGE

PRM

ONCOL

June-Sik Cho South Korea

Sang-Suk Han South Korea

D Najmark France

Byung Hee Koh South Korea

Ji Young Lee South Korea

Zhimei Huang China

Hiroyasu Ina Japan

Chang Jin Han South Korea

Ning‐lin Ge China

Bassem Hegab Saudi Arabia

June-Sik Cho South Korea

Y. Ajavon

200 ×0.8

HEPAT

112 ×0.8

EPIDE

134 ×0.9

SURGE

77 ×1.6

PRM

43 ×1.0

ONCOL

Citations per year, relative to Y. Ajavon Y. Ajavon (= 1×) peers June-Sik Cho

Countries citing papers authored by Y. Ajavon

Since Specialization

Citations

This map shows the geographic impact of Y. Ajavon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Ajavon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Ajavon more than expected).

Fields of papers citing papers by Y. Ajavon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Ajavon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Ajavon. The network helps show where Y. Ajavon may publish in the future.

Co-authorship network of co-authors of Y. Ajavon

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Ajavon. A scholar is included among the top collaborators of Y. Ajavon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Ajavon. Y. Ajavon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ajavon, Y., et al.. (2021). Use of Virtual Target Fluoroscopic Display of Three-Dimensional CO2 Wedged Hepatic Vein Portography for TIPS Placement. CardioVascular and Interventional Radiology. 44(11). 1817–1822. 4 indexed citations

Guyot, Erwan, Y. Ajavon, Véronique Grando, et al.. (2016). The CRP level and STATE score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolization. Digestive and Liver Disease. 48(9). 1088–1092. 14 indexed citations

Ajavon, Y., et al.. (2014). Local dose reference levels for abdominal interventional radiology procedures. 1 indexed citations

Lévi, Françis, Valérie Boige, Mohamed Hebbar, et al.. (2013). Final results of first European phase II trial of intravenous cetuximab (Cet) and hepatic artery infusion of irinotecan, 5-fluorouracil, and oxaliplatin in patients (pts) with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) after systemic treatment failure (OPTILIV, NCT00852228).. Journal of Clinical Oncology. 31(4_suppl). 466–466. 1 indexed citations

Bouchahda, Mohamed, Abdoulaye Karaboué, Marie-Christine Étienne-Grimaldi, et al.. (2013). Chronomodulated hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil (5-FU), and oxaliplatin (l-OHP) plus intravenous (iv) cetuximab (Cet) (Chrono-Optiliv) in patients with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) after treatment failure (European Phase II trial NCT 00852228).. Journal of Clinical Oncology. 31(15_suppl). 3606–3606. 1 indexed citations

Sellier, N., et al.. (2011). Percutaneous retrograde endovascular occlusion for pediatric varicocele. Journal of Pediatric Surgery. 46(3). 525–529. 14 indexed citations

Séror, Olivier, G. Nkontchou, Y. Ajavon, et al.. (2008). Large (≥5.0-cm) HCCs: Multipolar RF Ablation with Three Internally Cooled Bipolar Electrodes—Initial Experience in 26 Patients. Radiology. 248(1). 288–296. 90 indexed citations

Séror, Olivier, D. Haddar, G. Nkontchou, et al.. (2005). Radiofrequency Ablation for the Treatment of Liver Tumors in the Caudate Lobe. Journal of Vascular and Interventional Radiology. 16(7). 981–990. 38 indexed citations

Séror, Olivier, D. Haddar, Y. Ajavon, et al.. (2005). Large Infiltrative Hepatocellular Carcinomas: Treatment with Percutaneous Intraarterial Ethanol Injection Alone or in Combination with Conventional Percutaneous Ethanol Injection. Radiology. 234(1). 299–309. 22 indexed citations

10.

Séror, Olivier, Y. Ajavon, Laurent Castéra, et al.. (2005). Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. European Journal of Gastroenterology & Hepatology. 17(2). 179–184. 111 indexed citations

11.

Ajavon, Y., et al.. (2004). Catheterisme tubaire selectif : indications, faisabilite et precautions. Journal de Radiologie. 85(9). 1338–1338.

12.

Ajavon, Y., et al.. (1999). CT Demonstration of the 1996 AJCC-UICC Regional Lymph Node Classification for Lung Cancer Staging. Radiographics. 19(4). 899–899. 26 indexed citations

13.

Sibony, Mathilde, André Daniel Choury, Y. Ajavon, et al.. (1994). [Secondary sclerosing cholangitis and chemo-embolization with lipiodol].. PubMed. 18(2). 168–71. 9 indexed citations

14.

Caillet, H., et al.. (1992). Arterial and pseudoaneurysm ruptures complicating liver transplantation. European Radiology. 2(4). 2 indexed citations

15.

Caillet, H., et al.. (1991). [Imaging in the diagnosis of vascular complications after hepatic transplantation].. PubMed. 72(6-7). 381–8. 1 indexed citations

16.

Derhy, Serge, et al.. (1991). [Unresectable hepatic adenomas. Management by selective hepatic artery embolization].. PubMed. 15(5). 424–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact